NewAmsterdam Pharma NAMS SEC Filings

NASDAQ NAMS
$25.39 -0.46 (-1.78%)
As of: Sep 4, 2026 · 2:29 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document NewAmsterdam Pharma Co N.V. (NAMS) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index